Literature DB >> 23525950

Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma.

Danielle M Backes1, Afshan Siddiq, David G Cox, Federico C F Calboli, J Michael Gaziano, Jing Ma, Meir Stampfer, David J Hunter, Carlos A Camargo, Dominique S Michaud.   

Abstract

Previous studies have shown an inverse association between allergies and glioma risk; however, results for associations between single nucleotide polymorphisms (SNPs) of allergy-related genes and glioma risk have been inconsistent and restricted to a small number of SNPs. The objective of this study was to examine the association between 166 SNPs of 21 allergy-related genes and glioma risk in a nested case-control study of participants from three large US prospective cohort studies. Blood collection took place between 1982 and 1994 among the 562 included Caucasian participants (143 cases and 419 matched controls) prior to case diagnosis. Custom Illumina assay chips were used for genotyping. Logistic regression analyses, controlling for age and study cohort, were used to determine associations between each SNP and glioma risk. Statistically significant associations were found between rs2494262 and rs2427824 of the FCER1A gene, which encodes the alpha chain of the high affinity immunoglobulin E receptor, and glioma risk (nominal trend p values 0.01 and 0.03, respectively). Significant associations were also found between SNPs in IL10, ADAM33, NOS1 and IL4R and glioma risk. However, our analyses were not corrected for multiple comparisons and need to be interpreted with caution. Our findings with FCER1A SNPs provide further support for the link between allergies and risk of glioma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525950      PMCID: PMC3679351          DOI: 10.1007/s11060-013-1122-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

Review 1.  ADAM-33 surfaces as an asthma gene.

Authors:  Steven D Shapiro; Caroline A Owen
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

2.  Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women.

Authors:  Ji-Young Lee; Ae Kyung Park; Kyoung-Mu Lee; Sue K Park; Sohee Han; Wonshik Han; Dong-Young Noh; Keun-Young Yoo; Ho Kim; Stephen J Chanock; Nathaniel Rothman; Daehee Kang
Journal:  Carcinogenesis       Date:  2009-04-16       Impact factor: 4.944

Review 3.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.

Authors:  Judith Schwartzbaum; Anders Ahlbom; Beatrice Malmer; Stefan Lönn; Anthony J Brookes; Hani Doss; Waldemar Debinski; Roger Henriksson; Maria Feychting
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.

Authors:  Michael E Scheurer; E Amirian; Yumei Cao; Mark R Gilbert; Kenneth D Aldape; David G Kornguth; Randa El-Zein; Melissa L Bondy
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Atopy and risk of brain tumors: a meta-analysis.

Authors:  Eleni Linos; Tim Raine; Alvaro Alonso; Dominique Michaud
Journal:  J Natl Cancer Inst       Date:  2007-10-09       Impact factor: 13.506

7.  An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.

Authors:  Judith A Schwartzbaum; Anders Ahlbom; Stefan Lönn; Beatrice Malmer; Annette Wigertz; Anssi Auvinen; Anthony J Brookes; Helle Collatz Christensen; Roger Henriksson; Christoffer Johansen; Tina Salminen; Minouk J Schoemaker; Anthony J Swerdlow; Waldemar Debinski; Maria Feychting
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

8.  Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma.

Authors:  A V Brenner; M A Butler; S S Wang; A M Ruder; N Rothman; P A Schulte; S J Chanock; H A Fine; M S Linet; P D Inskip
Journal:  Carcinogenesis       Date:  2007-10-04       Impact factor: 4.944

9.  Allergy-related polymorphisms influence glioma status and serum IgE levels.

Authors:  Joseph L Wiemels; John K Wiencke; Karl T Kelsey; Michelle Moghadassi; Terri Rice; Kevin Y Urayama; Rei Miike; Margaret Wrensch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

10.  Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus.

Authors:  Stephan Weidinger; Christian Gieger; Elke Rodriguez; Hansjörg Baurecht; Martin Mempel; Norman Klopp; Henning Gohlke; Stefan Wagenpfeil; Markus Ollert; Johannes Ring; Heidrun Behrendt; Joachim Heinrich; Natalija Novak; Thomas Bieber; Ursula Krämer; Dietrich Berdel; Andrea von Berg; Carl Peter Bauer; Olf Herbarth; Sibylle Koletzko; Holger Prokisch; Divya Mehta; Thomas Meitinger; Martin Depner; Erika von Mutius; Liming Liang; Miriam Moffatt; William Cookson; Michael Kabesch; H-Erich Wichmann; Thomas Illig
Journal:  PLoS Genet       Date:  2008-08-22       Impact factor: 5.917

View more
  10 in total

1.  Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Authors:  E Susan Amirian; Deborah Marquez-Do; Melissa L Bondy; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2013-08-30       Impact factor: 2.984

2.  Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.

Authors:  Jun Guo; Lei Shi; Min Li; Jin Xu; Shushan Yan; Chuang Zhang; Guan Sun
Journal:  Tumour Biol       Date:  2013-08-27

3.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

4.  Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis.

Authors:  Peiqin Chen; Chao Chen; Kun Chen; Tao Xu; Chun Luo
Journal:  Tumour Biol       Date:  2014-12-04

Review 5.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

6.  P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.

Authors:  Fang He; Yi Xia; Huafeng Liu; Jin Li; Chao Wang
Journal:  Tumour Biol       Date:  2013-07-17

Review 7.  AllergoOncology - the impact of allergy in oncology: EAACI position paper.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; M Capron; C Corrigan; M Castells; D Dombrowicz; T R Daniels-Wells; J Fazekas; E Fiebiger; S Gatault; H J Gould; J Janda; D H Josephs; P Karagiannis; F Levi-Schaffer; A Meshcheryakova; D Mechtcheriakova; Y Mekori; F Mungenast; E A Nigro; M L Penichet; F Redegeld; L Saul; J Singer; J F Spicer; A G Siccardi; E Spillner; M C Turner; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-01-23       Impact factor: 13.146

8.  KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.

Authors:  Hui-Yi Lin; Po-Yu Huang; Chia-Ho Cheng; Heng-Yuan Tung; Zhide Fang; Anders E Berglund; Ann Chen; Jennifer French-Kwawu; Darian Harris; Julio Pow-Sang; Kosj Yamoah; John L Cleveland; Shivanshu Awasthi; Robert J Rounbehler; Travis Gerke; Jasreman Dhillon; Rosalind Eeles; Zsofia Kote-Jarai; Kenneth Muir; Johanna Schleutker; Nora Pashayan; David E Neal; Sune F Nielsen; Børge G Nordestgaard; Henrik Gronberg; Fredrik Wiklund; Graham G Giles; Christopher A Haiman; Ruth C Travis; Janet L Stanford; Adam S Kibel; Cezary Cybulski; Kay-Tee Khaw; Christiane Maier; Stephen N Thibodeau; Manuel R Teixeira; Lisa Cannon-Albright; Hermann Brenner; Radka Kaneva; Hardev Pandha; Srilakshmi Srinivasan; Judith Clements; Jyotsna Batra; Jong Y Park
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

Review 9.  Epidemiology of Brain and Other CNS Tumors.

Authors:  Quinn T Ostrom; Stephen S Francis; Jill S Barnholtz-Sloan
Journal:  Curr Neurol Neurosci Rep       Date:  2021-11-24       Impact factor: 6.030

Review 10.  Inverse Association between Prediagnostic IgE Levels and the Risk of Brain Tumors: A Systematic Review and Meta-Analysis.

Authors:  Chong Ma; Lei Cao; Jianping Zhao; Xing Ming; Ming Shang; Hailiang Zong; Hai Du; Kai Li; Xiaoguang He; Hongsheng Xu
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.